These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6104760)

  • 1. Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets.
    Paul SM; Rehavi M; Skolnick P; Goodwin FK
    Life Sci; 1980 Mar; 26(12):953-9. PubMed ID: 6104760
    [No Abstract]   [Full Text] [Related]  

  • 2. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
    Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
    Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites.
    Wennogle LP; Meyerson LR
    Eur J Pharmacol; 1982 Dec; 86(2):303-7. PubMed ID: 7160439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical heterogeneity of [3H]imipramine binding sites on human platelet membranes.
    Fomenko AM; Plyashkevich YG; Brusov OS; Demushkin VP
    Eur J Pharmacol; 1990 Sep; 189(2-3):175-83. PubMed ID: 2174789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity [3H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa.
    Weizman R; Carmi M; Tyano S; Apter A; Rehavi M
    Life Sci; 1986 Mar; 38(13):1235-42. PubMed ID: 3959752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of specific high affinity binding sites for [3H] imipramine in human brain.
    Rehavi M; Paul SM; Skolnick P; Goodwin FK
    Life Sci; 1980 Jun; 26(26):2273-9. PubMed ID: 7401921
    [No Abstract]   [Full Text] [Related]  

  • 11. Human platelets possess high-affinity binding sites for 3H-imipramine.
    Briley MS; Raisman R; Langer SZ
    Eur J Pharmacol; 1979 Oct; 58(3):347-8. PubMed ID: 510370
    [No Abstract]   [Full Text] [Related]  

  • 12. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific 3H-imipramine binding in human platelets. Influence of age and sex.
    Langer SZ; Briley MS; Raisman R; Henry JF; Morselli PL
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):189-94. PubMed ID: 7432551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers.
    Raisman R; Sechter D; Briley MS; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1981; 75(4):368-71. PubMed ID: 6803282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Ro 11-2465, a new psychotropic agent on the uptake of serotonin by human platelets--in vitro determination of the IC50.
    Lenehan T; Omer LM; Darragh A
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):147-52. PubMed ID: 7224716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.
    Rehavi M; Carmi R; Weizman A
    Eur J Pharmacol; 1988 Oct; 155(1-2):1-9. PubMed ID: 2854066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.